Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells

European Journal of Haematology

Volumn 61, Issue 4, 1998, Pages 266-271

  Laytragoon Lewin, N ^a,b   Duhony, E ^a   Bai, X F ^a   Mellstedt, H ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; CD40; CD95; CLL; PTK

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER CELL; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CROSS LINKING; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0031757785     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01713.x     Document Type: Article

References (26)

1. LIU Y, JOSHUA D, WILLIAMS G, SMITH C, GORDON J, MCLENNAN I. Mechanism of antigen-driven selection in germinal centres. Nature 1989: 342: 929-932
2. KNOX KA, GORDON J. Protein tyrosine phosphorylation is mandatory for CD40-mediated rescure of germinal center B cells from apoptosis. Eur J Immunol 1993: 23: 2578-2584.
3. FARIS M, GASKIN F, PARSONS J, FU S. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-KD tyrosine phosphorylated protein. J Exp Med 1994: 179: 1923-1931.
4. REN C, MORIO T, FU S, GEHA R. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cr2. J Exp Med 1994: 179: 673-680.
5. ITOH N, YONEHARA S, ISHII A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991: 66: 233-240.
6. OEHM A, BEHRMANN I, FALK W, et al. Purification and molecular cloning of the Apo-I antigen, a new member of the TNF/NGF receptor superfamily: sequence identity with the Fas antigen. J. Biol Chem 1992: 267: 10,709-10,718.
7. LEITHÄUSER F, DHEIN J, MECHTERSHEIMER G, et al. Constitutive and induced expression of Apo-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993: 69: 415-429.
8. MIYAWAKI T, UEHARA T, NIBU R, et al. (1992) Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992: 149: 3753-3758.
9. DANIEL P, KRAMMER P. Activation induces sensitivity toward Apo-1 (CD95)-mediated apoptosis in human B cells. J Immunol 1994: 152: 5624-5632.
10. KABELITZ D, POHL T, PECHHOLD K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 1993: 14: 338-339.
11. TRAUTH B, KLAS C, PETERS A, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989: 245: 301-305.
12. NAGATA S, SUDA T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995: 16: 39-43.
13. SCHENA M, GOTTARDI D, GHIA P, et al. The role of bcl-2 in the pathogenesis of B chronic lymphocytic leukemia. Leuk Lymph 1993: 11: 173-179.
14. HAMBLIN T, OSCIER D, YOUNG B. Autoimmunity in chronic lymphocytic leukemia. J Clin Path 1986: 39: 713-716.
15. ROSEN F, COOPER M, WEDGWOOD R. The primary immunodeficiencies. N Engl J Med 1995: 333: 431-440.
16. PAULI S, ROSEN A, EHLIN-HENRIKSSON B, et al. (1989) The human B lymphocyte and carcinoma antigen. CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol 1989: 142: 159-164.
17. BEN-ALSSA H, PAULIE S, KOHO H, et al. Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissue. Anticancer Res 1986: 6: 165-170.
18. CRAWFORD D, CATOVSKY D. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. Immunology 1993: 80: 40-44.
19. SÖDERBERG O, CHRISTIANSEN I, CARLSSON M, NILSSON K. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukemia cells. Scand J Immunol 1997: 45: 706-714.
20. LOWIN B, HAHNE M, MATTMANN C, TSCHOPP J. Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994: 370: 650-653.
21. LOWIN B, MATTMANN C, HAHNE M, TSCHOPP J. Comparison of Fas (ApoI/CD95)-and perforin-mediatedin primary T lymphocytes. Inter Immunol 1996: 8: 57-63.
22. SCHLZE-OSTHOFF K, KRAMMER P, DRÖGE W. Divergent signaling via Apo-I/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 1994: 13: 4587-4596.
23. SATO T, IRIE S, KITADA S, REED J. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995: 268: 411-415.
24. YONEHARA S, ISHII A, YONEHARA M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989: 169: 1747-1756.
25. MAPARA M, BARGOU R, ZUGCK C, et al. Apo-I mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with Bcl-2 oncogene expression. Eur J Immunol 1993: 23: 702-713.
26. WANG D, FREEMAN G, LEVINE H, RITZ J, ROBERTSON M. Role of the CD40 and CD95 (Apo I/Fas) antigens in the apoptosis of human B cell malignancies. Br J Haematol 1997: 97: 409-417.